Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taroh Satoh

Showing results (71-80 of 277) with videos related to

Pageof 28
Sort By:
Plos One|November 17, 2015
Combined Analysis of Plasma Amphiregulin and Heregulin Predicts Response to Cetuximab in Metastatic Colorectal CancerKimio Yonesaka, Naoki Takegawa, Taroh Satoh, et al.
In Vivo (Athens, Greece)|October 31, 2019
Combination Therapy With S-1, Oxaliplatin and Leucovorin in Patients With Advanced Esophageal Squamous Cell CarcinomaNaohiro Nishida, Makoto Yamsaki, Kazuki Odagiri, et al.
Japanese Journal of Clinical Oncology|March 1, 2013
A Phase I/II trial of radiotherapy concurrent with TS-1 plus cisplatin in patients with clinically resectable type 4 or large type 3 gastric cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group OGSG1205Motohiro Imano, Hiroshi Furukawa, Masaki Yokokawa, et al.
Scientific Reports|June 4, 2021
Comprehensive profiling of novel epithelial-mesenchymal transition mediators and their clinical significance in colorectal cancerSatoshi Ishikawa, Naohiro Nishida, Shiki Fujino, et al.
Experimental and Therapeutic Medicine|September 13, 2012
Genotoxic therapy stimulates error-prone DNA repair in dormant hepatocellular cancer stem cellsShimpei Nishikawa, Hideshi Ishii, Naotsugu Haraguchi, et al.
Cancer Chemotherapy and Pharmacology|June 25, 2016
Impact of capecitabine and S-1 on anticoagulant activity of warfarin in patients with gastrointestinal cancerTsuyoshi Hata, Toshihiro Kudo, Daisuke Sakai, et al.
Ebiomedicine|July 3, 2015
Clinical Validation of a Multiplex Kit for RAS Mutations in Colorectal Cancer: Results of the RASKET (RAS KEy Testing) Prospective, Multicenter StudyTakayuki Yoshino, Kei Muro, Kensei Yamaguchi, et al.
Anticancer Research|August 28, 2025
Efficacy and Safety of S-1 and Oxaliplatin With Radiotherapy for Anorectal CancerNoriko Wada, Naohiro Nishida, Mitsunobu Takeda, et al.
Investigational New Drugs|September 18, 2009
Phase I clinical and pharmacokinetic study of sorafenib in combination with carboplatin and paclitaxel in patients with advanced non-small cell lung cancerIsamu Okamoto, Masaki Miyazaki, Ryotaro Morinaga, et al.
Cancer Chemotherapy and Pharmacology|August 20, 2011
Phase I study of cediranib in combination with cisplatin plus fluoropyrimidine (S-1 or capecitabine) in Japanese patients with previously untreated advanced gastric cancerTaroh Satoh, Yasuhide Yamada, Kei Muro, et al.
Pageof 28

Showing results (71-80 of 277) with videos related to

Sort By:
Pageof 28
Plos One|November 17, 2015
Combined Analysis of Plasma Amphiregulin and Heregulin Predicts Response to Cetuximab in Metastatic Colorectal CancerKimio Yonesaka, Naoki Takegawa, Taroh Satoh, et al.
In Vivo (Athens, Greece)|October 31, 2019
Combination Therapy With S-1, Oxaliplatin and Leucovorin in Patients With Advanced Esophageal Squamous Cell CarcinomaNaohiro Nishida, Makoto Yamsaki, Kazuki Odagiri, et al.
Japanese Journal of Clinical Oncology|March 1, 2013
A Phase I/II trial of radiotherapy concurrent with TS-1 plus cisplatin in patients with clinically resectable type 4 or large type 3 gastric cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group OGSG1205Motohiro Imano, Hiroshi Furukawa, Masaki Yokokawa, et al.
Scientific Reports|June 4, 2021
Comprehensive profiling of novel epithelial-mesenchymal transition mediators and their clinical significance in colorectal cancerSatoshi Ishikawa, Naohiro Nishida, Shiki Fujino, et al.
Experimental and Therapeutic Medicine|September 13, 2012
Genotoxic therapy stimulates error-prone DNA repair in dormant hepatocellular cancer stem cellsShimpei Nishikawa, Hideshi Ishii, Naotsugu Haraguchi, et al.
Cancer Chemotherapy and Pharmacology|June 25, 2016
Impact of capecitabine and S-1 on anticoagulant activity of warfarin in patients with gastrointestinal cancerTsuyoshi Hata, Toshihiro Kudo, Daisuke Sakai, et al.
Ebiomedicine|July 3, 2015
Clinical Validation of a Multiplex Kit for RAS Mutations in Colorectal Cancer: Results of the RASKET (RAS KEy Testing) Prospective, Multicenter StudyTakayuki Yoshino, Kei Muro, Kensei Yamaguchi, et al.
Anticancer Research|August 28, 2025
Efficacy and Safety of S-1 and Oxaliplatin With Radiotherapy for Anorectal CancerNoriko Wada, Naohiro Nishida, Mitsunobu Takeda, et al.
Investigational New Drugs|September 18, 2009
Phase I clinical and pharmacokinetic study of sorafenib in combination with carboplatin and paclitaxel in patients with advanced non-small cell lung cancerIsamu Okamoto, Masaki Miyazaki, Ryotaro Morinaga, et al.
Cancer Chemotherapy and Pharmacology|August 20, 2011
Phase I study of cediranib in combination with cisplatin plus fluoropyrimidine (S-1 or capecitabine) in Japanese patients with previously untreated advanced gastric cancerTaroh Satoh, Yasuhide Yamada, Kei Muro, et al.
Pageof 28